Posted on 13 December 2013

Shionogi announced over 30 partnering / licensing deals since 2005, with almost consistent dealmaking deals in 2010. Analysis of the partnering deals shows a strong emphasis on partnerships in infectives, CNS and respiratory diseases. Read the full story

Posted on 27 November 2013

Egalet has entered into a definitive collaboration and pharma licensing deal with Shionogi for the development and potential commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates using Egalet's proprietary technology. Read the full story

Posted on 09 April 2013

Five Japanese life sciences giants pharma alliances with the Bill and Melinda Gates Foundation and Japan’s government to develop new medicines, vaccines, and diagnostics for infectious diseases in developing countries. Read the full story

Posted on 30 October 2012

Shionogi, a top 50 big pharma company will take a 10 percent stake in Viiv Healthcare, a AIDS drug joint venture between GlaxoSmithKline and Pfizer in a pharma partnering pact, in exchange for its rights to the drug Dolutegravir Read the full story